Trademark Details For X-MAN (Serial Number 85807317)

Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; Molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes for scientific and research purposes; Biological and chemical reagents, namely, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use;

Protein cell lysates. genomic DNA preparations and formalin fixed, paraffin embedded (FFPE) engineered tumor tissue mimics for medical diagnostic use;

Custom cell-line engineering services; Scientific research in the field of genetics and genetic engineering, namely, gene-editing services, DNA modeling services, gene engineering services, establishing patient genotypes; Bio-technology, pharmaceutical and scientific testing, research and development services relating to genetics, and providing advice, consultancy and information services related thereto; biological research; pharmaceutical research services; drug discovery services; Scientific research and development services for lead identification and validation; Scientific research and development services for target identification and validation; Pharmaceutical research, namely, identification of patient-relevant drug targets, optimization of drug candidates for clinical development; Laboratory diagnostic services, namely, diagnosis of genetic mutations for clinical or research purposes and the design of molecular reference standards for assay development, clinical diagnostic quality control and proficiency schemes for the medical diagnostic services industry; medicinal research services, namely, hit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lines, chemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; Scientific research and development services relating to targeting therapies to individuals; Scientific research and development services relating to combining therapies for individuals; research and development relating to reagents; Scientific research in the field of disease modeling; Medical and scientific research, namely, designing and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indications;